TickerFacts.

C21 Investments Inc. (CWLXF): Revenue

Annual figures by period end, from SEC filings.

$32.61M
Year ended 2026-03-31
$33.47M2021-01-31: $33.47M2022-01-31: $32.98M2023-01-31: $28.89M2024-01-31: $28.29M2025-03-31: $30.12M2026-03-31: $32.61M$32.61M
2021-01-31 Revenue (USD) 2026-03-31
Period endedRevenueChange YoYSource filing
2026-03-31$32.61M+8.3%2026-06-12, From 2025-04-01
2025-03-31$30.12Mn/a2026-06-12, From 2024-04-01
No annual figure between 2024-01-31 and 2025-03-31.
2024-01-31$28.29M-2.1%2025-06-23, From 2023-02-01
2023-01-31$28.89M-12.4%2024-08-08, From 2022-02-01
2022-01-31$32.98M-1.4%2023-07-28, From 2021-02-01
2021-01-31$33.47Mn/a2023-07-28, From 2020-02-01

Revenue at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
C21 Investments Inc. (CWLXF)2026-03-31$32.61M+8.3%
Leef Brands Inc. (LEEEF)2025-12-31$34.79M+22.1%
Synergy CHC Corp. (SNYRQ)2025-12-31$30.38M-12.8%
Cyanotech Corp (CYAN)2025-03-31$24.21M+5.0%
Charlie's Holdings, Inc. (CHUC)2025-12-31$20.92M+169.4%
Bon Natural Life Ltd (BON)2025-09-30$18.67M-21.7%
Fitlife Brands, Inc. (FTLF)2025-12-31$81.46M+26.4%
Mannatech Inc (MTEX)2025-12-31$108.04M-8.3%
Niagen Bioscience, Inc. (NAGE)2025-12-31$129.42M+29.9%

Compare CWLXF, LEEEF, SNYRQ, CYAN side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗